These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26284243)

  • 21. Genetically modified organisms and food security in Southern Africa: conundrum and discourse.
    Muzhinji N; Ntuli V
    GM Crops Food; 2021 Jan; 12(1):25-35. PubMed ID: 32687427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biosafety regulatory frameworks in Kenya, Nigeria, Uganda and Sweden and their potential impact on international R&D collaborations.
    Ongu I; Olayide P; Alexandersson E; Mugwanya Zawedde B; Eriksson D
    GM Crops Food; 2023 Dec; 14(1):1-17. PubMed ID: 36987578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Databases on biotechnology and biosafety of GMOs.
    Degrassi G; Alexandrova N; Ripandelli D
    Environ Biosafety Res; 2003; 2(3):145-60. PubMed ID: 15612413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Need for an "integrated safety assessment" of GMOs, linking food safety and environmental considerations.
    Haslberger AG
    J Agric Food Chem; 2006 May; 54(9):3173-80. PubMed ID: 16637668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opportunities for Orphan Crops: Expected Economic Benefits From Biotechnology.
    Zambrano P; Wood-Sichra U; Ruhinduka RD; Phillip D; Nin Pratt A; Komen J; Kikulwe EM; Falck Zepeda J; Dzanku FM; Chambers JA
    Front Plant Sci; 2022; 13():825930. PubMed ID: 35873974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Readiness for Environmental Release of Genetically Engineered (GE) Plants in Uganda.
    Zawedde BM; Kwehangana M; Oloka HK
    Front Bioeng Biotechnol; 2018; 6():152. PubMed ID: 30406096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulatory challenges for GM crops in developing economies: the African experience.
    Nang'ayo F; Simiyu-Wafukho S; Oikeh SO
    Transgenic Res; 2014 Dec; 23(6):1049-55. PubMed ID: 24821674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Harnessing genomics to improve health in the Eastern Mediterranean Region - an executive course in genomics policy.
    Acharya T; Rab MA; Singer PA; Daar AS
    Health Res Policy Syst; 2005 Jan; 3(1):1. PubMed ID: 15663786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of agribiotechnology and biosafety regulations used to assess safety of genetically modified crops in Bangladesh.
    Nasiruddin KM; Nasim A
    J AOAC Int; 2007; 90(5):1508-12. PubMed ID: 17956000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Status of research, regulations and challenges for genetically modified crops in India.
    Shukla M; Al-Busaidi KT; Trivedi M; Tiwari RK
    GM Crops Food; 2018; 9(4):173-188. PubMed ID: 30346874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The evolution of China's regulation of agricultural biotechnology.
    Liang J; Yang X; Jiao Y; Wang D; Zhao Q; Sun Y; Li Y; Wu K
    aBIOTECH; 2022 Dec; 3(4):237-249. PubMed ID: 36533267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetically modified crops do not present variations in pollen viability and morphology when compared to their conventional counterparts.
    Soares D; Vertuan H; Bacalhau F; José M; Crivellari A; Belchior GG; Berger GU
    PLoS One; 2023; 18(5):e0285079. PubMed ID: 37126533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic impacts of policies affecting crop biotechnology and trade.
    Anderson K
    N Biotechnol; 2010 Nov; 27(5):558-64. PubMed ID: 20478422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An Asian perspective on GMO and biotechnology issues.
    Teng PP
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():237-40. PubMed ID: 18296345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Labeling of food containing genetically modified organisms: international policies and Brazilian legislation].
    Costa TE; Marin VA
    Cien Saude Colet; 2011 Aug; 16(8):3571-82. PubMed ID: 21860957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An improved maize marketing system for African countries: the case of Zimbabwe.
    Child B; Muir K; Blackie M
    Food Policy; 1985 Nov; 10(4):365-73. PubMed ID: 12280292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring the Impact of Tensions in Stakeholder Norms on Designing for Value Change: The Case of Biosafety in Industrial Biotechnology.
    Asin-Garcia E; Robaey Z; Kampers LFC; Martins Dos Santos VAP
    Sci Eng Ethics; 2023 Mar; 29(2):9. PubMed ID: 36882674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The EU regulatory framework on genetically modified organisms (GMOs).
    Bruetschy C
    Transgenic Res; 2019 Aug; 28(Suppl 2):169-174. PubMed ID: 31321701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Key elements in a strategic approach to capacity building in the biosafety of genetically modified organisms.
    Araya-Quesada M; Degrassi G; Ripandelli D; Craig W
    Environ Biosafety Res; 2010; 9(1):59-65. PubMed ID: 21134346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Agriculture and biotechnology in Pacific countries.
    Shigaki T
    Recent Pat Food Nutr Agric; 2014; 6(1):33-7. PubMed ID: 25412740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.